cGMP-Dependent Protein Kinase Inhibitors in Health and Disease.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 2, p. 269, doi. 10.3390/ph6020269
- By:
- Publication type:
- Article
Works matching IS 14248247 AND DT 2013 AND VI 6 AND IP 2
Results: 7
1
2
NMDA Receptor Modulators in the Treatment of Drug Addiction.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 2, p. 251, doi. 10.3390/ph6020251
- By:
- Publication type:
- Article
3
RNAi Therapeutic Platforms for Lung Diseases.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 2, p. 223, doi. 10.3390/ph6020223
- By:
- Publication type:
- Article
4
Elucidating the Function of Penetratin and a Static Magnetic Field in Cellular Uptake of Magnetic Nanoparticles.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 2, p. 204, doi. 10.3390/ph6020204
- By:
- Publication type:
- Article
5
Relationships between Cargo, Cell Penetrating Peptides and Cell Type for Uptake of Non-Covalent Complexes into Live Cells.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 2, p. 184, doi. 10.3390/ph6020184
- By:
- Publication type:
- Article
6
Dendrimers for siRNA Delivery.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 2, p. 161, doi. 10.3390/ph6020161
- By:
- Publication type:
- Article
7
siRNA Genome Screening Approaches to Therapeutic Drug Repositioning.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 2, p. 124, doi. 10.3390/ph6020124
- By:
- Publication type:
- Article